Elicio Therapeutics, Inc. (ELTX) stock
ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.06 (-3.85%)
Close on Nov 13, 2026Market cap $39.42MP/E –Yield –
Elicio Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Elicio Therapeutics's operating margin for the twelve months ending Mar 31, 2023 was -3946.1%. For fiscal 2022 it was -1031.4%, against -138.8% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -1031.4% | −892.6 |
| FY2021 | Dec 31, 2021 | -138.8% | +1780.4 |
| FY2020 | Dec 31, 2020 | -1919.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | -954.4% | +2424.2 |
| Q1 FY2022 | Mar 31, 2022 | -878.9% | +4495.4 |
| Q4 FY2021 | Dec 31, 2021 | 56.4% | +3073.8 |
| Q3 FY2021 | Sep 30, 2021 | -1079.3% | +321.5 |
| Q2 FY2021 | Jun 30, 2021 | -3378.5% | −1009.7 |
| Q1 FY2021 | Mar 31, 2021 | -5374.4% | −3921.3 |
| Q4 FY2020 | Dec 31, 2020 | -3017.4% | – |
| Q3 FY2020 | Sep 30, 2020 | -1400.8% | – |
| Q2 FY2020 | Jun 30, 2020 | -2368.9% | – |
| Q1 FY2020 | Mar 31, 2020 | -1453.1% | – |
See a number that looks wrong?